BWX Technologies Stock (BWXT) Opinions on Nuclear Renaissance and Analyst Upgrades - Quiver Quantitative
π Jefferies initiated a Buy rating on BWXT with an $181 price target, highlighting the company's strong position in nuclear components and U.S. Navy contracts.
π° BWX Technologies reported Q2 2026 revenues of $901.6 million, marking an 18.01% increase compared to the same period in the prior year.
π― Analysts have set a median price target of $230.00 for BWXT, with Deutsche Bank offering a high target of $255.00 and Wells Fargo at $200.00.
ποΈ The company maintains an $8.4 billion backlog, reinforcing its role as a core beneficiary in the expanding nuclear supply chain.
π CEO Rex D. Geveden sold 10,000 shares for approximately $1.7 million over the past six months with no insider purchases recorded during that period.
π¦ JPMorgan Chase & Co. added 2.65 million shares to its portfolio in Q2 2026, representing an estimated investment of $516.6 million.
βοΈ Investors view BWXT as a technical leader with manufacturing scale advantages specifically in SMR development and fuel cycle activities.
π Institutional ownership saw net additions from major firms like Select Equity Group (+134.6%) and First Trust Advisors (+49.2%) in the most recent quarter.
πΌ The company received $143.25 million in award payments over the last year, with enriched uranium conversion services accounting for the majority of that value.
- Jefferies initiated a Buy rating with an $181 price target, citing strong positioning in nuclear components and U.S. Navy contracts.
- Q2 2026 revenues surged to $901.6 million, reflecting an 18.01% year-over-year increase driven by core business operations.
- The company holds a substantial $8.4 billion backlog, providing visibility into future revenue streams and validating its market position.
- Deutsche Bank set a high price target of $255.00, reflecting confidence in the firm's technical barriers and manufacturing scale.
- Major institutional investor JPMorgan Chase added over $516 million to its BWXT holdings in Q2 2026, signaling strong institutional demand.
- Analyst consensus includes a median price target of $230.00, with multiple firms including Truist and TD Securities offering targets above $210.
- The company is viewed as a core 'pick-and-shovel' beneficiary in the nuclear renaissance, benefiting from policy support for domestic infrastructure.
- CEO Rex D. Geveden executed four sales totaling 10,000 shares worth approximately $1.7 million over the past six months with no insider purchases.
- Some hedge funds completely exited their positions in Q2 2026, including Arrowstreet Capital and Qube Research which removed all holdings.